Form 4: Oragenics Inc. President J Michael Redmond Acquires 100,000 Options
SEC Form 4 Filing
J Michael Redmond, President of Oragenics Inc., reports the acquisition of 100,000 employee stock options.
Summary
- J Michael Redmond, President of Oragenics Inc. (OGEN), filed a Form 4 with the SEC on September 20, 2024.
- The form reports a transaction that occurred on September 19, 2024.
- Redmond acquired 100,000 employee stock options with an exercise price of $0.48.
- The options vest immediately and expire on September 19, 2034.
- The options are directly owned.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard reporting of stock option grants.
Positives
- The immediate vesting of the options could be seen as a positive incentive for the President.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 09/19/2024 | Date of earliest transaction: Redmond acquired 100,000 employee stock options. |
| 09/19/2024 | Options vest immediately. |
| 09/19/2034 | Options expiration date. |
| 09/20/2024 | Date of Form 4 filing. |
Keywords
Form 4, Oragenics Inc, OGEN, J Michael Redmond, Employee Stock Options, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.